Inhibition/NN
of/IN
nuclear/JJ
factor/NN
kappaB/NN
activation/NN
attenuates/VBZ
apoptosis/NN
resistance/NN
in/IN
lymphoid/JJ
cells/NNS
./.

Death-inducing/NN
ligands/NNS
(/(
DILs/NNS
)/)
such/JJ
as/IN
tumor/NN
necrosis/NN
factor/NN
alpha/NN
(/(
TNFalpha/NN
)/)
or/CC
the/DT
cytotoxic/JJ
drug/NN
doxorubicin/NN
have/VBP
been/VBN
shown/VBN
to/TO
activate/VB
a/DT
nuclear/JJ
factor/NN
kappaB/NN
(/(
NFkappaB/NN
)/)
-dependent/JJ
program/NN
that/WDT
may/MD
rescue/VB
cells/NNS
from/IN
apoptosis/NN
induction/NN
./.
=====
We/PRP
demonstrate/VBP
here/RB
that/IN
TRAIL/NN
(/(
TNF-related/JJ
apoptosis-inducing/NN
ligand/NN
)/)
,/,
a/DT
recently/RB
identified/VBN
DIL/NN
,/,
also/RB
activates/VBZ
NFkappaB/NN
in/IN
lymphoid/JJ
cell/NN
lines/NNS
in/IN
a/DT
kinetic/JJ
similar/JJ
to/TO
TNFalpha/NN
./.
=====
NFkappaB/NN
activity/NN
is/VBZ
independent/JJ
from/IN
FADD/NN
,/,
caspases/NNS
,/,
and/CC
apoptosis/NN
induction/NN
./.
=====
To/TO
study/VB
the/DT
influence/NN
of/IN
NFkappaB/NN
activity/NN
on/IN
apoptosis/NN
mediated/VBN
by/IN
TRAIL/NN
,/,
CD95/NN
,/,
TNFalpha/NN
,/,
or/CC
doxorubicin/NN
,/,
NFkappaB/NN
activation/NN
was/VBD
inhibited/VBN
using/VBG
the/DT
proteasome/NN
inhibitor/NN
N-acetyl-L-leucinyl-L-leucinyl-L-norleucinal/NN
or/CC
transient/JJ
overexpression/NN
of/IN
mutant/JJ
IkappaBalpha/NN
./.
=====
Sensitivity/NN
for/IN
induction/NN
of/IN
apoptosis/NN
was/VBD
markedly/RB
increased/VBN
by/IN
these/DT
treatments/NNS
in/IN
apoptosis/NN
sensitive/JJ
cell/NN
lines/NNS
./.
=====
Moreover/RB
,/,
both/CC
in/IN
cell/NN
lines/NNS
and/CC
in/IN
primary/JJ
leukemia/NN
cells/NNS
that/WDT
are/VBP
resistant/JJ
towards/IN
induction/NN
of/IN
apoptosis/NN
by/IN
DILs/NN
and/CC
doxorubicin/NN
,/,
antagonization/NN
of/IN
NFkappaB/NN
activity/NN
partially/RB
restored/VBD
apoptosis/NN
sensitivity/NN
./.
=====
These/DT
data/NNS
suggest/VBP
that/IN
inhibition/NN
of/IN
NFkappaB/NN
activation/NN
may/MD
provide/VB
a/DT
molecular/JJ
approach/NN
to/TO
increase/VB
apoptosis/NN
sensitivity/NN
in/IN
anticancer/JJ
treatment/NN
./.